check_circleStudy Completed
Hypertension, Pulmonary
Bayer Identifier:
18515
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Epidemiology and treatment patterns of paediatric PAH (Pulmonary arterial hypertension)
Trial purpose
To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013
Key Participants Requirements
Sex
BothAge
NaN - 18 YearsTrial summary
Enrollment Goal
2691Trial Dates
October 2015 - January 2016Phase
N/ACould I Receive a placebo
NoProducts
UnspecifiedAccepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Boston, United States |
Primary Outcome
- Incidence rate of PAH (pulmonary arterial hypertension)date_rangeTime Frame:Retrospective analysis of three year periodenhanced_encryptionNoSafety Issue:
- Prevalence rate of PAHdate_rangeTime Frame:Retrospective analysis of three year periodenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Assigned drug treatment for PAH measured using the MarketScan databaseDescription of pulmonary hypertension-targeted drugs prescribed in the study population and changes during the study perioddate_rangeTime Frame:Retrospective analysis of three year periodenhanced_encryptionNoSafety Issue:
- Diagnostic procedures performed among PAH patients measured using the MarketScan databasedate_rangeTime Frame:Retrospective analysis of three year periodenhanced_encryptionNoSafety Issue:
- Prevalence of comorbidities among PAH patientsdate_rangeTime Frame:Retrospective analysis of three year periodenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A